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Intracytoplasmic injection with testicular spermatozoa has become a routine treatment in fertility clinics.
Spermatozoa can be recovered in half of patients with nonobstructive azoospermia. The use of immature germ
cells for intracytoplasmic injection has been proposed for cases in which no spermatozoa can be retrieved.
However, there are low pregnancy rates following intracytoplasmic injection using round spermatids from men
with no elongated spermatids or spermatozoa in their testes. The in vitro culture of immature germ cells to
more mature stages has been proposed as a means to improve this poor outcome. Several years after the
introduction of intracytoplasmic injection with elongating and round spermatids, uncertainty remains as to
whether this approach can be considered a safe treatment option. This review outlines the clinical and scientific
data regarding intracytoplasmic injection using immature germ cells and in vitro matured germ cells.
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& INTRODUCTION
Intracytoplasmic sperm injection (ICSI) has constituted a
breakthrough in the treatment of severe male-factor infertility
(1). This technique was initially introduced as a treatment
for severe oligoasthenoteratozoospermia using ejaculated
sperm. In 1993, the first successful pregnancy using
spermatozoa that had been directly extracted from the testis
of an azoospermic man was achieved (2). Azoospermia is
present in 1% of the general male population and in 10 to 15%
of infertile men. There are two major etiologic categories of
azoospermia: obstructive azoospermia (OA) and nonobstruc-
tive azoospermia (NOA). In OA, complete spermatogenesis
is observed during histological analysis, whereas in NOA,
either germ cell aplasia (a Sertoli cell-only pattern), matura-
tion arrest or tubular sclerosis and atrophy is revealed by
histological analysis. The histology of the latter three may or
may not show focal spermatogenesis. The most mature stage
of the male gamete at the end of spermiogenesis is the
elongated spermatid. After spermiation, spermatozoa are
released into the tubular lumen. These spermatozoa become
functional during the passage through the epididymis.
Testicular sperm retrieval is successful in virtually 100% of
patients with OA, and sufficient numbers of spermatozoa can
be obtained for ICSI and/or cryopreservation. However, the
recovery of fully elongated spermatids or spermatozoa fails
in approximately 50% of NOA men (3). The only hope for
these patients to father their own genetic children is the use of
more immature germ cells for ICSI. Spermatids are the
earliest cells in the male germ cell lineage with a haploid
number of chromosomes. In various studies using mouse,
hamster and rabbit models, two techniques, elongated
spermatid injection (ELSI) and round spermatid injection
(ROSI), have been successfully employed to fertilize a mature
oocyte with such immature germ cells, resulting in the
delivery of healthy offspring (4-7). Although the fertilization,
pregnancy and live birth rates were low in these animal
models, the results demonstrated the potential of spermatids
to contribute to normal fertilization and embryonic develop-
ment. Based on these observations, Edwards suggested the
use of spermatids for ICSI in humans when sperm at more
mature stages were not available (8). In humans, the injection
of spermatids leading to fertilization and early cleavage was
reported by Vanderzwalmen (9). The first reported successful
births were by Tesarik using round spermatids from the
ejaculate (10) and by Fishel using elongated spermatids
extracted from the testis (11). The first reports of human
pregnancies following round spermatid injection involved
round spermatid nucleus injection (ROSNI), but all of these
pregnancies ended in spontaneous abortions (12). In the mid-
nineties, several IVF centers used testicular spermatids for
ICSI, and most of the reported pregnancies were achieved
using late spermatids. When round spermatids were used,
the pregnancy rate was much lower. More than 15 years after
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the first live birth achieved with ROSI, fewer than ten
children have been born worldwide using this technique.
The in vitro culture of immature germ cells to more
mature stages of spermatogenesis has been suggested as an
approach to improve the poor live birth rate associated with
ROSI and as a tool to improve both the identification and
the selection of spermatids used for ICSI.
Despite a number of reports of the delivery of healthy
offspring in humans following the use of immature germ
cells for ICSI, several ethical concerns have been raised. In
some countries, e.g., the United Kingdom, government
regulations have banned the use of spermatids for ICSI.
& BASICS OF SPERMATOGENESIS AND
SPERMIOGENESIS
The term ‘‘spermatogenesis’’ refers to all of the processes
and events involved in the production of mature gametes
that occur within the seminiferous tubules of the testis.
Spermatogenesis begins with the division of a testicular stem
cell and ends with the formation of a mature spermatozoon,
and it can be divided into three major stages (13):
1) The mitotic proliferation and differentiation of diploid
germ cells (i.e., spermatogonia) into diploid (2n) primary
spermatocytes.
2) The meiotic division of tetraploid germ cells (i.e.,
spermatocytes) into four haploid germ cells called sperma-
tids; the first meiotic division produces two secondary
spermatocytes, which are separated into haploid (1n)
spermatids during the second meiotic division. The second-
ary spermatocytes contain a set of haploid chromosomes in
duplicate form. The meiotic process is a critical event during
gametogenesis because it involves the recombination of
genetic material, a reduction in the chromosome number
and the development of spermatids.
3) The transformation of the haploid germ cells (spermatids)
into testicular sperm (i.e., spermiogenesis). Spermatids are
mitotically inactive round cells that undergo a remarkable and
complicated transformation leading to the ultimate production
of differentiated elongated spermatids and spermatozoa. This
transformation includes the condensation and structural
shaping of the cell nucleus, the formation of the flagellum
and the expulsion of a large portion of the cytoplasm. The
overall process is termed ‘‘spermiogenesis.’’ When spermato-
genesis is completed, the cytoplasmic connections between the
sperm and the Sertoli cells are broken, followed by the release
of the sperm from the germinal epithelium into the tubular
lumen. This process is referred to as spermiation.
The coordinating mechanism behind the processes of
human spermatogenesis and spermiogenesis remains
unclear. When maturation arrest occurs at the primary
spermatocyte stage, the germ cells still contain a diploid
number of chromosomes and are therefore not suitable for
ICSI. When maturation arrest occurs at the round spermatid
stage, the germ cells contain a haploid number of chromo-
somes and theoretically possess all of the genetic informa-
tion needed to fertilize mature oocytes by ICSI.
& ICSI WITH SPERMATIDS: CLINICAL EXPERIENCE
Following the reports of results in animals, several groups
have described the use of round or elongated spermatids,
retrieved from either the ejaculate or testicular tissue, to
treat men with NOA when no testicular spermatozoa could
be retrieved. Either intact round spermatids (ROSI), round
spermatid nuclei (ROSNI) or elongated spermatids (ELSI)
are injected into the oocyte. Although ELSI, ROSI and
ROSNI were introduced more than 15 years ago, the
number of reported pregnancies has remained extremely
limited.
ELSI
A 2002 review summarized the literature on ICSI with
elongated spermatids (ELSI) (14). Elongated spermatids
isolated either from ejaculate or directly from testicular tissue
have been successfully used. An analysis of the studies using
late spermatids for injection indicated that this technique was
associated with a low fertilization rate (48.4%) but an
otherwise acceptable pregnancy rate (28.9%) (14). The overall
results of ICSI using testicular elongated spermatids were
comparable to those using testicular spermatozoa (14). The
retrospective nature of most of the studies and the presence
of patient selection bias and even publication bias may
explain these results. Furthermore, some of the ELSI studies
also included men who exhibited normal spermatogenesis.
ROSI
The first successful reports of ROSI in humans described
seven azoospermic men who had round spermatids but no
mature spermatozoa in their ejaculate (10). Round sperma-
tids were used for ICSI and produced two viable pregnan-
cies.
Sousa et al. reviewed reports of ICSI with round
spermatids isolated from either ejaculate or testicular tissue.
Compared with ELSI, the success rates of ROSI are
dramatically lower; the latter approach appears to be
clinically inefficient, with a 21.8% fertilization rate and a
2.8% clinical pregnancy rate (14). Since 2002, no clinical
pregnancies have been reported following ROSI (15-20). In
summary, seven clinical pregnancies have been reported
overall after the use of ROSI: three with spermatids from the
ejaculate and four with spermatids extracted from the testis.
Antinori is the only researcher to have reported three
clinical pregnancies after ROSI in the absence of spermato-
zoa in the preliminary ejaculate or in biopsies (21,22). After
the publication of Antinori’s work, no pregnancies have
been reported following the use of round spermatids from
patients with a complete absence of elongated spermatids or
spermatozoa in preliminary ejaculate or diagnostic testicu-
lar biopsies. Based on the above results, it may be concluded
that ROSI is an inefficient approach for treating infertility in
azoospermic men with primary testicular failure who
exhibit no spermatozoa in testicular biopsies.
ROSNI
On the basis of animal experiments, the ROSNI technique
has been suggested to overcome some of the disadvantages
of ROSI: (1) the injecting micropipettes used for ROSNI have
a smaller diameter, which reduces the risk of oocyte
damage, and (2) the presence of a large amount of
cytoplasm around the spermatid nucleus (in ROSI) may
impede the transformation into the male pronucleus (23).
Human experiments, however, have revealed that oocyte
degeneration after ROSI is not adversely affected by the use
of a larger microinjection pipette nor by the presence of a
cytoplasmic layer surrounding the spermatid nucleus; the
rupture of the cytoplasmic membrane and the nuclear
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envelope is rapidly achieved after microinjection (14). Sousa
reported a low oocyte degeneration rate (9%) in 33 ROSI
cycles following the injection of 200 oocytes (14).
Most human pregnancies reported after ROSNI ended in
spontaneous abortion (12). To our knowledge, only one
publication has reported live births (three) following ROSNI
(23,24).
Secondary spermatocyte injection (SECSI)
There have also been isolated reports of the successful use
of human secondary spermatocytes for ICSI; including the
delivery of a healthy boy (25). However, limited clinical
benefits can be expected from this approach because most
NOA men with secondary spermatocytes in their testicular
biopsies also have more mature germ cells (23). Furthermore,
no additional reports have confirmed the success of this
approach in humans.
As a result of the overall disappointing results of
spermatid injection (ROSI, ROSNI and ELSI) following its
initial hype, most IVF programs stopped using spermatid
injection in the mid-nineties. Consequently, there have been
no published reports of spermatid injection since that time
period.
& ICSI WITH SPERMATIDS: IDENTIFICATION IS
CRUCIAL
In most of the reports of ICSI with spermatids, the
spermatid stage that was used is unclear identified. The
adoption of a clear terminology is needed to avoid
confusion regarding success rates, so that reliable conclu-
sions can be drawn and results can be compared between
different centers (26).
A critical problem in the use of spermatids for ICSI is the
identification of spermatids within a heterogeneous popula-
tion of round cells that have been obtained from either
testicular tissue or the ejaculate. In an unstained wet
preparation under an inverted microscope, haploid sper-
matids can be divided into four categories according to their
shape, amount of cytoplasm and tail size: round (Sa, Sb1),
elongating (Sb2), elongated (Sc, Sd1), and fully elongated
(Sd2) spermatids (27). Elongating or elongated spermatids
are easy to recognize, but the identification of round
spermatids is more difficult. The presence of pathological
conditions makes this identification even more difficult
because the cells are retrieved from patients with abnormal
spermiogenesis. Tesarik and Mendoza (28) have described a
method to distinguish round spermatids from other round
cells in the ejaculate (leucocytes, lymphocytes, monocytes,
erythrocytes, Sertoli cells, spermatogonia and primary and
secondary spermatocytes) according to the shape and size of
the cell and its nucleus. A developing acrosomal granule
can be recognized as a bright spot adjacent to the spermatid
nucleus; however, this bright spot may be easily confused
with a vacuole (29). Misidentification can lead to the
injection of round cells that are not round spermatids,
which might explain the low success rates of ROSI. Using
the Hoffman modulation contrast microscopy, which is
employed by most centers for the ICSI procedure, the
identification of round spermatids is extremely difficult
(29,30). Optimal identification techniques should be devel-
oped and applied in everyday clinical practice, allowing
correctly selected round spermatids to be injected. Although
staining procedures may clearly reveal the presence of
round spermatids, this approach has diagnostic value only;
it is not feasible in clinical practice (31,32). Yamanaka et al.
have characterized round spermatids using confocal scan-
ning laser microscopy (33); however, this equipment is
expensive and therefore not accessible to all laboratories.
The use of phase-contrast optics on an inverted microscope
is a simple and reliable method of identifying round
spermatids (29).
& ICSI WITH SPERMATIDS: IS THERE A TARGET
GROUP?
ROSI has been proposed as an ART technique for males
with primary testicular failure resulting from complete
maturation arrest. However, maturation arrest at the level
of the round spermatid is rare; Shulze et al. (34) reviewed
1,418 stained biopsies from 766 azoospermic men and
identified late maturation arrest (i.e., round spermatid arrest)
in only seven men (0.9%). Silber and Johnson (35) reviewed
125 stained biopsies from men with unexplained NOA and
found no evidence of arrest at the round spermatid stage. In
biopsies where round spermatids were observed, elongated
spermatids or even spermatozoa were invariably present as
well. Furthermore, in our experience, an extensive search of
wet preparations revealed identifiable round spermatids
only in patients for whom the more mature stages of
development were also present (29). Therefore, round
spermatids may be observed in the testicular biopsies of
only a limited number of patients from whom no sperma-
tozoa or elongated spermatids can be recovered.
& IN VITRO MATURATION AND ART
In vivo spermatogenesis is a long and complex process of
germ cell development within the seminiferous tubules and
is regulated not only by gonadotropins but also by
interactions between spermatogenic cells and somatic
Sertoli cells (36,37). In theory, in vivo arrest may be
overcome by in vitro culture, either by co-culturing isolated
germ cells on a somatic cell monolayer or by culturing
isolated segments of seminiferous tubules. In vitro culture
can target either the meiotic or postmeiotic maturation
(spermiogenesis) of germ cells. Therefore, in vitro culture
has been proposed to improve the selection against
spermatids or spermatozoa carrying DNA damage and to
overcome in vivo maturation arrest (38).
Postmeiotic differentiation via the in vitro culture of
round spermatids to the elongating stage may be a way to
replace ROSI with ELSI, as the latter is technically much
simpler and yields a superior outcome (28). Aslam and
Fishel (39) observed flagellar growth in 22% of round
spermatids during the first 4-8 h of culture in modified
Eagle’s minimum essential medium with no hormonal
supplementation. Follicle-stimulating hormone (FSH)-inde-
pendent rapid flagellar growth in vitro by round spermatids
has also been reported by others (40,41). In contrast to flagellar
growth, the processes of nuclear condensation, the peripheral
migration and protrusion of the spermatid nucleus, as well as
the differentiation of the acrosome, are strictly dependent on
the presence of FSH in the culture medium (41). Cremades
et al. demonstrated that round spermatids could mature into
elongating and elongated spermatids in vitro after seven days
of culture at 32 C˚ in microdrops of Vero cell-conditioned
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medium and that these cells could successfully fertilize
oocytes to form blastocysts (42).
The in vitro culture of germ cells may be useful for
overcoming the inadvertent use of apoptotic spermatids in
assisted reproduction and may therefore increase the
fertilization rate (43). However, many authors have reported
that both developmental capacity and clinical outcomes
remain extremely poor after the use of in vitro-cultured
round spermatids and have concluded that in vitro culture
offers no clinical benefit apart from improving the fertiliza-
tion rate (27,44,45).
The births of two healthy babies have been reported
following ICSI with elongated spermatids obtained after the
in vitro culture of round spermatids from a patient with
complete maturation arrest at the round spermatid stage
(46,47). Later, the birth of two healthy babies (twins) was
achieved by the same group using an in vitro culture system
that supported the postmeiotic differentiation of round
spermatids from patients with incomplete arrest of sper-
miogenesis and a high frequency of apoptosis among
postmeiotic germ cells (48).
Arrest at the primary spermatocyte stage is the most
common type of maturation arrest in men with NOA (49).
To overcome this type of arrest, the in vitro transmeiotic
differentiation of primary spermatocytes has been pro-
posed.
Testicular biopsies of patients with obstructive azoosper-
mia and normal spermatogenesis were cultured in vitro for
24 h by Tesarik et al. (41). Whole segments of the
seminiferous tubules and Sertoli cells were cultured in the
presence or absence of recombinant FSH and testosterone
(T) at a temperature close to that of the human testis. The
presence of recombinant FSH increased the proportions of
primary and secondary spermatocytes undergoing meiotic
progression and postmeiotic differentiation (41). The addi-
tion of testosterone enhanced the effects of FSH on meiosis
and spermiogenesis by preventing the apoptosis of Sertoli
cells in culture, whereas no effect was observed for the
addition of T without FSH (50). Compared with the normal
kinetics of the human germinal epithelium (51), a surpris-
ingly rapid maturation (two days) was observed when
culturing primary and secondary spermatocytes to elon-
gated spermatids (50).
Tanaka et al. were the first to report the in vitro
development of four round spermatids derived from a
single primary spermatocyte using co-culture with a Vero
cell line (52). They observed in vitro meiotic division that
was independent of the addition of FSH and T, in contrast to
earlier reports by Tesarik et al. (50). The newly divided cells
were confirmed to be round spermatids using chromosomal
analysis (52). Although co-culture with Vero cells could
replace the use of Sertoli cells as a support for in vitro
meiosis, the Vero cells appeared unable to support
postmeiotic differentiation to later stages, i.e., elongated
spermatids or spermatozoa (52).
The same in vitro culture conditions that had been
previously recommended by Tesarik were used to culture
testicular cells from five men with maturation arrest at the
primary spermatocyte stage. Spermatids from two of the
men were cultured after two days, and the injection of these
in vitro cultured elongated spermatids successfully ferti-
lized oocytes and resulted in normally developing embryos
in both cases and healthy twin in one case (46). Later Tesarik
et al. reported on the birth of a third healthy child after the
injection of in vitro matured elongated spermatids from
men with maturation arrest at the primary spermatocyte
stage (53).
These findings provide strong evidence that premeiotic
arrest at the primary spermatocyte stage can be overcome in
vitro under optimized culture conditions and can result in
haploid cells with full reproductive capacity.
& ART WITH SPERMATIDS: A SAFE OPTION?
Apart from its low overall success rate, the safety of ICSI
with immature haploid germ cells has been questioned. One
of the major concerns about any reproductive technology
is the possibility of genetic and epigenetic risks to the
offspring.
There are concerns related to genomic imprinting follow-
ing spermatid injection. Although genes are expressed
equally from the two parental alleles, a small subgroup of
genes are differentially expressed depending on whether
they were inherited maternally or paternally. Genes that
display inhibited expression when derived from the maternal
germline are termed ‘‘maternally imprinted,’’ and genes with
inhibited expression when transmitted by the father are
termed ‘‘paternally imprinted.’’ The differential expression
of the paternal and maternal alleles of imprinted genes is
related to differential DNA methylation patterns in these
genes. Genomic imprinting primarily occurs during gameto-
genesis and may be incomplete or defective in immature
gametes or in gametes that have matured under abnormal
conditions, e.g., in an in vitro culture (54).
During spermatogenesis, the histone-to-protamine transi-
tion ensures protection from mutation of the spermatid
DNA. However, in a knock-out mouse model with
abnormal spermiogenesis, the round spermatids displayed
increased levels of DNA damage caused by a deficiency in
the histone-to-protamine transmission (55). In NOA men, a
high frequency of DNA damage in round spermatids has
been reported in patients with complete spermiogenesis
failure (54), whereas abnormal chromatin packing in
elongated spermatids has been reported (56). Spermatids
differ from mature sperm in their chromatin structure, and
this difference may affect the epigenetic behavior of the
paternal genome (57). The strict control of DNA methylation
in the preimplantation embryo is necessary for normal
development.
Preimplantation genetic diagnosis (PGD) has been pro-
posed to increase both the implantation rate and safety of
ROSI. Benkhalifa et al. reported the results of preimplanta-
tion genetic diagnosis (PGD) performed on embryos obtained
by ROSI (20). Their data indicated that the failure of ROSI to
produce pregnancy and live births occurs at both the
prezygotic and postzygotic stages and is primarily caused
by aneuploidy. Although Benkhalifa et al. did not report any
increases in chromosomal or other genetic abnormalities in
the rare pregnancies that occurred, they concluded that ROSI
should not be used in ART programs.
Additional concerns about ICSI with immature haploid
germ cells are related to the immaturity of the cytoplasm.
The cytoplasm of male gametes contains two factors that are
important for normal embryonic development: the centro-
somes and oocyte-activating factor (OAF). Abnormal or
damaged centrosomes due to spermatid immaturity may
cause abnormal spindle formation and may explain the
arrest, mosaicism and anomalies observed in embryos that
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develop after spermatid injection (58). The injection of
human round spermatids into oocytes produces normal
fertilization, which indicates that human spermatogenic
cells have developed OAF- and calcium oscillation-inducing
capabilities by the round spermatid stage (49), whereas the
round spermatids of rodents require oocyte activation after
injection (60). Aneuploidy may result from either immature
centrosomes (which prevent the formation of normal
microtubule-organizing centers) or abnormal oocyte activa-
tion.
In 2000, Zech et al. reported two major congenital
malformations in four pregnancies achieved using ELSI:
one fetus exhibited the Arnold-Chiari malformation, and
another fetus displayed hydrocephaly combined with
trisomy 9 (47, XY,+9) in all of the amniotic cells (61). There
have been no further published reports of abnormalities
caused by imprinting disorders related to the use of
immature germ cells. Epigenetic failure in germline cells is
of great concern because it may only manifest later in life
(such as through an increased predisposition to cancer)
and/or be silently transmitted to the next generation (62).
Finally, there are some concerns about the accelerated
speed of the in vitro development of germ cells from men
with in vivo maturation arrest. There are suspicions of a
possible negative effect on DNA when some of the essential
checkpoints of in vivo development are bypassed (47).
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